Sionna Therapeutics (SION) Q2 2026 earnings — TrendMatrix coverage
MISS · WIDER LOSS-2.4% vs estimateEPS -$0.66 vs -$0.64 est
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
Key numbers
- Reported EPS
- -$0.66
- Estimate
- -$0.64
- Surprise
- -2.4%
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Report record · Q2 2026
How the report landed
Sionna Therapeutics (SION) reported a wider loss than forecast — diluted EPS of -$0.66 against the -$0.64 estimate (a 2.4% shortfall).